alexa Self-care In Keloid Management With Nanoparticles/microneedles For Drug Delivery
ISSN: 2157-7439

Journal of Nanomedicine & Nanotechnology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference on Nanotek & Expo
December 02-04, 2013 Hampton Inn Tropicana, Las Vegas, NV, USA

Xu Chenjie
ScientificTracks Abstracts: J Nanomed Nanotechnol
DOI: 10.4172/2157-7439.S1.013
Abstract
Keloids are proliferative fibrous growths that result from an excessive tissue response to skin trauma. They frequently persist at the site of injury, often recur after excision and always overgrow the boundaries of the original wound. Although they are benign with no malignant potential, disfigurement from keloids lead to considerable physical and psychological adverse effects. Keloids are more prevalent in young individuals (age 20-30) with darker skin pigmentation. Research from National University of Singapore also indicates that keloids are three times more common in Chinese patients than Caucasian patients. A variety of techniques have been utilized to treat keloids. However, all treatments are administered by clinicians, which require clinic visits by the patients and increase medical cost. Most of them are invasive and are fraught with pain during the treatment. For example, the current standard treatment of keloids with intralesional corticosteroid injections requires a prolonged treatment period at regular intervals of administration by physician. Today, self-care with miniaturized and automated devices are presenting as possible options in disease treatment. Responding to this trend, the ultimate goal of this project is to realize the self-administered treatment of keloids. Specifically, we intend to revolutionize the strategy in keloid treatment, by replacing the clinician-controlled drug administration with the patient- manageable drug delivery. We have built a prototype technology, in which skin-penetrating microneedles and drug-releasing nanoparticle are used to deliver drugs in a minimally invasive way for keloid treatment. This technology prevented the growth and proliferation of keloid fibroblast in a 3D skin model
Biography
Xu Chenjie received his Ph.D. from Brown University in 2009, focusing on biomedical applications of novel platforms of magnetic nanoparticles. From 2009-2012, he was a research associate at Harvard-MIT HST in the field of stem cell engineering and drug delivery. His main field of research is the biomedical application of functional nanoparticles. More specifically, he is interested in realizing the early detection, diagnosis, and cost- effective treatment of major diseases at Asia with nanoparticle-related nanotechnology and. He has published 32 papers and filed 2 patents so far with 2400 citations and H-index of 18
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords